Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,503
Closed -$1.26M – 84
2026
Q1
$1.26M Sell
10,503
-1,313
-11% -$152K 0.56% 52
2025
Q4
$1.24M Sell
11,816
-279
-2% -$26.2K 0.42% 63
2025
Q3
$1.02M Buy
12,095
+176
+1% +$14.5K 0.33% 66
2025
Q2
$944K Sell
11,919
-1,616
-12% -$128K 0.33% 66
2025
Q1
$1.21M Buy
13,535
+27
+0.2% +$2.52K 0.45% 69
2024
Q4
$1.34M Sell
13,508
-13
-0.1% -$1.34K 0.44% 67
2024
Q3
$1.54M Buy
13,521
+80
+0.6% +$9.5K 0.51% 61
2024
Q2
$1.66M Buy
13,441
+26
+0.2% +$3.35K 0.6% 57
2024
Q1
$1.77M Buy
+13,415
New +$1.65M 0.71% 50

Other funds holding MRK

NIA Impact Advisors's MRK Position: Q2 2026 in Review

NIA Impact Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 10,503 shares — an estimated $1.26M sold.

NIA Impact Advisors first reported a position in MRK in Q1 2024 and held it in 9 quarters. The position peaked at $1.77M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • NIA Impact Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • NIA Impact Advisors sold 10,503 Merck shares in Q2 2026, an estimated $1.26M.
  • NIA Impact Advisors first reported a position in Merck in Q1 2024 and held it in 9 quarters.
  • NIA Impact Advisors's Merck position peaked at $1.77M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.